Where Will Novavax Be in 3 Years?
With a coronavirus vaccine on the verge of worldwide commercialization, Novavax (NASDAQ: NVAX) is probably a few months away from being able to sit pretty and watch the money roll in. Now that the stock has captured the attention of investors everywhere, the next question is whether the company can turn its soon-to-be success into the consistent and long-term kind.
In my view, Novavax is going to be in a stronger place by the middle of the decade. But, I'm of the opinion that the work it did before the pandemic is going to be almost as important as its much-anticipated coronavirus jab moving forward. Let's take a look at its current slate of projects to see why.
Image source: Getty Images
Source Fool.com
